CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
81 hedge funds and large institutions have $32.8M invested in CureVac in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 18 closing their positions.
18% more call options, than puts
Call options by funds: $497K | Put options by funds: $421K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.38% less ownership
Funds ownership: 6.34% → 4.96% (-1.4%)
7% less funds holding
Funds holding: 87 → 81 (-6)
21% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 29
32% less capital invested
Capital invested by funds: $48.3M → $32.8M (-$15.5M)
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.47M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.32M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$373K |
| 4 |
Jane Street
New York
|
+$184K |
| 5 |
Squarepoint
New York
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.41M |
| 2 |
BlackRock
New York
|
-$2.93M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$1.87M |
| 4 |
Millennium Management
New York
|
-$1.5M |
| 5 |
Walleye Capital
New York
|
-$639K |
CVAC Hedge Fund Activity: Q3 2024 in Review
81 institutional investors reported a position in CureVac (CVAC) for Q3 2024, worth a combined $32.8M — down 32% from $48.3M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CVAC and 12 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 23 added.
The largest buyer was Citadel Advisors, adding an estimated $2.47M. The largest seller was Point72 Asset Management, cutting an estimated $5.41M.
- 81 institutional investors held CureVac (CVAC) as of Q3 2024, down from 87 in Q2 2024.
- Funds reported $32.8M of CureVac stock for Q3 2024, down 32% quarter-over-quarter.
- 12 funds opened new CureVac positions in Q3 2024 and 18 closed out, a net change of -6 holders.
- The largest CureVac buyer in Q3 2024 was Citadel Advisors, an estimated $2.47M added.
- The largest CureVac seller in Q3 2024 was Point72 Asset Management, an estimated $5.41M sold.
Based on aggregated 13F filings for Q3 2024.